Odyssey Health, Inc. Provides Update on Company and the Progress of Concussion Drug Development
23 nov. 2022 08h30 HE
|
Odyssey Health, Inc
Las Vegas, Nevada, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical...
NLP (Natural Language Processing) in Healthcare and Life Sciences Markets: Statistical, Hybrid, IVR, OCR, Clinical Trail Matching, Drug Discovery - Global Analysis & Forecasts to 2027
23 nov. 2022 06h33 HE
|
Research and Markets
Dublin, Nov. 23, 2022 (GLOBE NEWSWIRE) -- The "NLP in Healthcare and Life Sciences Market by Component (Solutions and Services), NLP Type (Statistical, Hybrid), NLP Technique (IVR, OCR), Application...
Hopebridge and Akiva Partner for Virtual Reality Additive Design Clinical Pilots
21 nov. 2022 08h00 HE
|
Hopebridge
Indianapolis, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Hopebridge Autism Therapy Centers, the largest autism therapy healthcare provider in the nation, is advancing autism spectrum disorder (ASD) research...
Patient Engagement Solutions Market Size & Share to Surpass $41.0 Bn by 2028 | Vantage Market Research
17 nov. 2022 04h41 HE
|
Vantage Market Research
WASHINGTON, Nov. 17, 2022 (GLOBE NEWSWIRE) -- The global Patient Engagement Solutions Market was valued at $16.1 Billion in 2021 and is expected to reach $41.0 Billion by 2028, registering a CAGR of...
Odyssey Health, Inc. Schedules Annual Meeting of Stockholders
15 nov. 2022 08h00 HE
|
Odyssey Health, Inc
Las Vegas, Nevada, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc. (the "Company" or "Odyssey"), a medical technology company focused on...
US Military Health System Research Study Deploys Clinical ink's Self-Testing Mobile Platform to Understand Long COVID
01 nov. 2022 12h28 HE
|
Clinical Ink
Horsham, Pennsylvania, USA, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Clinical ink, a global life science technology company, has developed a self-testing app to measure cognitive impairment in patients...
Odyssey Health Inc. Files Full US Patent Application on Novel Breath-Propelled Intranasal Brain-Drug Delivery Device
01 nov. 2022 08h30 HE
|
Odyssey Health, Inc
Las Vegas, Nevada, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc. (the "Company" or "Odyssey"), announces that it has filed for United...
The Cooper Institute’s Legacy Celebration Honors Women in Fitness Iconic Runner Kathrine Switzer as Keynote Speaker at Nov. 3 Gala
28 oct. 2022 18h21 HE
|
Cooper Aerobics
DALLAS, Oct. 28, 2022 (GLOBE NEWSWIRE) -- The Cooper Institute hosts its annual Legacy event “Celebrating Women in Fitness” on Thursday, November 3, 7-9 p.m., at the Arts District Mansion. The...
Isotope Production System begins commercial production of cancer-fighting lutetium-177
24 oct. 2022 02h30 HE
|
Bruce Power
Tiverton, Ontario, Oct. 24, 2022 (GLOBE NEWSWIRE) -- An international collaboration between Bruce Power, Isogen (a Kinectrics and Framatome company) and ITM Isotope Technologies Munich SE (ITM),...
Sermonix Pharmaceuticals Shares Additional Findings From Its ELAINE 1 Clinical Study at the 4th Annual Congress of the International Society of Liquid Biopsy
21 oct. 2022 10h00 HE
|
Sermonix Pharmaceuticals Inc.
COLUMBUS, Ohio, Oct. 21, 2022 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat ESR1-mutated...